WashU Team IDs Recurrent, Outcome-Related Mutations in AML | GenomeWeb

By Andrea Anderson

NEW YORK (GenomeWeb News) – The presence or absence of mutations in the DNA methyltransferase gene DNMT3A can help identify a sub-group of acute myeloid leukemia patients prone to poor outcomes, according to a paper appearing online last night in the New England Journal of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.